These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26393058)

  • 1. Market size and sales pattern of tuberculosis drugs in the Philippines.
    Islam T; van Weezenbeek C; Vianzon R; Garfin AM; Hiatt T; Lew WJ; Tisocki K
    Public Health Action; 2013 Dec; 3(4):337-41. PubMed ID: 26393058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size and usage patterns of private TB drug markets in the high burden countries.
    Wells WA; Ge CF; Patel N; Oh T; Gardiner E; Kimerling ME
    PLoS One; 2011 May; 6(5):e18964. PubMed ID: 21573227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends of Private Drugs' Sales and Costs Incurred by Patients on Anti-tuberculosis Drugs in Selected Districts of Jharkhand (2022): Results From Sub-national TB-Free Certification.
    Sinha R; Rana RK; Kujur A; Jahnavi G; Kumar M; Venugopal V; Priya N; Kujur M; Jha RR; Barnwal R; Nishant N; Murmu N; Pathak R; T A; Prasad R; Dayal R; Modi B; Purty AJ; Bn S; Nair D; Kumar D
    Cureus; 2023 Oct; 15(10):e47296. PubMed ID: 38021489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data.
    Arinaminpathy N; Batra D; Maheshwari N; Swaroop K; Sharma L; Sachdeva KS; Khaparde S; Rao R; Gupta D; Vadera B; Nair SA; Rade K; Kumta S; Dewan P
    BMC Infect Dis; 2019 Jun; 19(1):539. PubMed ID: 31217003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016-2018.
    Sahoo SK; Pathni AK; Krishna A; Moran AE; Cohn J; Bhatia S; Maheshwari N; Sharma B
    Glob Heart; 2021; 16(1):51. PubMed ID: 34381673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responding to the multidrug-resistant tuberculosis crisis: mainstreaming programmatic management to the Philippine National Tuberculosis Programme.
    Quelapio MI; Mira NR; Orillaza-Chi RB; Belen V; Muñez N; Belchez R; Egos GE; Evangelista M; Vianzon R; Tupasi TE
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):751-7. PubMed ID: 20487615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of tuberculosis in an urban setting in Nepal: public-private partnership.
    Newell JN; Pande SB; Baral SC; Bam DS; Malla P
    Bull World Health Organ; 2004 Feb; 82(2):92-8. PubMed ID: 15042230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking Public Private Mix (PPM) Performance in the Tuberculosis Program: How Is Care Seeking Impacting This Model in High TB Burden Countries?
    Adepoju VA; Oladimeji O; Horsburgh CR
    Healthcare (Basel); 2022 Jul; 10(7):. PubMed ID: 35885812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Market assessment of tuberculosis diagnostics in Brazil in 2012.
    TB Diagnostics Market Analysis Consortium
    PLoS One; 2014; 9(8):e104105. PubMed ID: 25099237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successfully Engaging Private Providers to Improve Diagnosis, Notification, and Treatment of TB and Drug-Resistant TB: The EQUIP Public-Private Model in Chennai, India.
    Ananthakrishnan R; Richardson MD; van den Hof S; Rangaswamy R; Thiagesan R; Auguesteen S; Kamp N
    Glob Health Sci Pract; 2019 Mar; 7(1):41-53. PubMed ID: 30926737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis control and the private health sector in Bolivia: a survey of pharmacies.
    Lambert ML; Delgado R; Michaux G; Volz A; Van der Stuyft P
    Int J Tuberc Lung Dis; 2004 Nov; 8(11):1325-9. PubMed ID: 15581200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis drug issues: prices, fixed-dose combination products and second-line drugs.
    Laing RO; McGoldrick KM
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S194-207. PubMed ID: 11144553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of multidrug-resistant tuberculosis in Thailand.
    Maranetra KN
    Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public-private mix DOTS in the Philippines.
    Mantala MJ
    Tuberculosis (Edinb); 2003; 83(1-3):173-6. PubMed ID: 12758208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
    Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tuberculosis treatment in private pharmacies, Kathmandu Valley, Nepal.
    Hurtig AK; Pande SB; Baral SC; Porter JD; Bam DS
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):730-6. PubMed ID: 10949324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.